SCHOTT Pharma AG & Co. KGaA header image

SCHOTT Pharma AG & Co. KGaA

1SXP

Equity

ISIN DE000A3ENQ51 / Valor 128964250

Xetra (2026-08-28)
EUR 23.50+0.21%

SCHOTT Pharma AG & Co. KGaA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

SCHOTT Pharma AG & Co. KGaA, a subsidiary of SCHOTT AG, specializes in the production of drug containment and delivery systems, including pharmaceutical syringes, cartridges, vials, and ampoules. With a global presence in 34 countries and 16 GMP-compliant manufacturing sites, the company produces over 13 billion drug containers annually, catering to the needs of the pharmaceutical industry. Employing more than 4,700 professionals across North America, Europe, Asia, and Latin America, SCHOTT Pharma collaborates with leading industry partners to ensure the safe, fast, and reliable delivery of medicines. The company operates under the ownership of the Carl Zeiss Foundation and is headquartered in Mainz, Germany. In the fiscal year 2021, SCHOTT Pharma contributed to SCHOTT AG's overall sales of 2.5 billion euros, leveraging its expertise in borosilicate glass and high-grade pharmaceutical COC polymer to meet diverse drug formulation requirements.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2.17%1Y
%3Y
%5Y

Performance

33.4%1Y
38.0%3Y
38.0%5Y

Volatility

Market cap

4100 M

Market cap (USD)

Daily traded volume (Shares)

50,548

Daily traded volume (Shares)

1 day high/low

25.1 / 24.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Globus Medical Inc
Globus Medical Inc Globus Medical Inc Valor: 18329123
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.52%USD 82.97
Tenet Healthcare Corp
Tenet Healthcare Corp Tenet Healthcare Corp Valor: 19722583
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 266.80
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%INR 1,935.30
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.41%USD 64.04
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%INR 853.35
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%USD 6.50
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.18%USD 22.44
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 432.42
Ardent Health Partners Inc
Ardent Health Partners Inc Ardent Health Partners Inc Valor: 136301364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%USD 10.96
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.50%CHF 26.80